The importance of PI3K in cancer is underscored by the anticancer effect of drugs that inhibit downstream effectors of PI3K/Akt signaling, such as rapamycin, an mTOR inhibitor (Yuan and Cantley, 2008). This evidence concerns the gene MTOR and cancer.